glp 1 agonist pcos Efficacy of GLP-1 Receptor Agonists in Obese Women with PCOS" by Ellie Fischer Superior metabolic improvement of polycystic

Trials show these agents can reduce glycated hemoglobin (HbAc) by ~1% or more and induce weight reductions of 510% of body weight in many patients ( [7] ) ( [6] )

For the primary composite endpoint of myocardial infarction, stroke or all-cause mortality, benchmarking identified high agreement between the reference trials and their emulations for all individual endpoints except for all-cause mortality in SUSTAIN-6, informing subsequent analyses

A rare case of a large bowel obstruction due to tirzepatide

A randomized controlled trial of dapagliflozin plus once-weekly exenatide versus placebo in individuals with obesity and without diabetes: metabolic effects and markers associated with bodyweight loss

Peptides 173 , 171149 (2024)